A supported IrO₂–RuO₂@Ru (3 : 1) catalyst exhibits an IrO₂-enriched surface and the intrinsic activity is enhanced obviously compared to that of an alloyed Ir₃RuO₂ catalyst.
No takes yet. Share an insight, caveat, or question.
Li et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: